Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Sawhney MS, McDougall H, Nelson DB, Bond JH. Fecal occult blood test in patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory drugs. Dig Dis Sci. 2010. doi:10.1007/s10620-010-1150-4.
Van Rossum LGV, Van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterol. 2008;135:82–90.
Hol L, Van Leerdam ME, Van Ballegooijen M, et al. Screening for colorectal cancer: randomized trial comparing guaiac-based and immunochemical fecal occult blood testing and flexible sigmoidoscopy. Gut. 2010;59:62–68.
Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol. 2009;104:739–750.
Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal cancer and the American College of Radiology. Gastroenterol. 2008;134:1570–1595.
Chung DC. Stool DNA testing and colon cancer prevention. AGA Perspectives. 2009;7(12):12–13.
McCarthy DM. Occult GI bleeding in NSAID users—the base of the iceberg (editorial). Clinical Gastroenterol & Hepatol. 2005;3:1071–1074.
Chan FKL, Ching JYL, Hung LCT, et al. Clopidogrel versus aspirin and omeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238–244.
Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549.
Atkin WS. UK Flexible Sigmoidoscopy Screening trial investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicenter randomised trial. Lancet. 2002;359:1291–1300.
Hoff G, Grotmol T, Skovlund E, et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomized controlled trial. BMJ. 2009;338(7707):b1846–b1852.
Ransohoff DF. Lessons from the UK sigmoidoscopy screening trial. Lancet. 2002;359:1266–1267.
Dominitz JA, Robertson DJ. Does flexible sigmoidoscopy reduce colorectal cancer incidence and mortality? Gastroenterol. 2009;137:1529–1531.
Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the US preventative services task force. Annals Int Med. 2008;149:638–658.
Kato J, Morikawa T, Altamirano JT, et al. Combination of sigmoidoscopy and fecal immunochemical test to detect proximal colon neoplasia. Clin Gastroenterol Hepatol. 2009;7(12):1341–1346.
Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Int Med. 2009;150:1–8.
Ransohoff DA. How much does colonoscopy reduce colon cancer mortality? Ann Int Med. 2009;150:50–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McCarthy, D.M. Probing the Occult: Testing for Blood in the Stools. Dig Dis Sci 55, 1503–1505 (2010). https://doi.org/10.1007/s10620-010-1247-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1247-9